Search
for
Sort by
Research 661–690 of 1000+
- Topical Cyclosporine in Alopecia Areata
- Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
- Alopecia areata: An update
- Alopecia areata: a new treatment plan
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Investigative guidelines for alopecia areata
- Trichohyalin is a Potential Major Autoantigen in Human Alopecia Areata
- Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild‐to‐moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator‐blinded trial
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- The Therapeutic Effect and the Changed Serum Zinc Level after Zinc Supplementation in Alopecia Areata Patients Who Had a Low Serum Zinc Level
- Twice Weekly 5 mg Dexamethasone Oral Pulse in the Treatment of Extensive Alopecia Areata
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
- Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- JAK Inhibitors for Treatment of Alopecia Areata
- The Role of Micronutrients in Alopecia Areata: A Review
- Factors Associated with Severity of Alopecia Areata
- Use of the pulsed infrared diode laser (904 nm) in the treatment of alopecia areata
- Topical photochemotherapy for alopecia areata
- Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation
- Imbalance of T‐helper 17 and regulatory T cells in patients with alopecia areata
- Oxidative Stress in Alopecia Areata: A Case–Control Study
- Sulfasalazine for alopecia areata
- Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures
- Alopecia areata as another immune‐mediated disease developed in patients treated with tumour necrosis factor‐α blocker agents
- Combination of topical garlic gel and betamethasone valerate cream in the treatment of localized alopecia areata: A double-blind randomized controlled study
- Dietary soy oil content and soy‐derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice
- The role of lymphocytes in the development and treatment of alopecia areata
- Treatment of severe alopecia areata with intralesional steroid injections.